Risk of retinal vein occlusion in colorectal cancer patients receiving anti-vascular endothelial growth factors – a population-based cohort study

BACKGROUND: Anti−vascular endothelial growth factors (VEGFs) treatment has been associated with an increased risk of thromboembolic events. Therefore, the use of anti−VEGFs for patients with colorectal cancers (CRC) has raised concerns about the potential risk of retinal vein occlusion (RVO), an ocu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Wan-Ju Annabelle, Chung, Wei-Pang, Shao, Shih-Chieh, Lai, Edward Chia-Cheng, Chen, Yi-Chen, Ho, Chung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265868/
https://www.ncbi.nlm.nih.gov/pubmed/37316803
http://dx.doi.org/10.1186/s12885-023-11037-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265868/
https://www.ncbi.nlm.nih.gov/pubmed/37316803
http://dx.doi.org/10.1186/s12885-023-11037-4

Ejemplares similares